Treatment with botulinum toxin in a patient with myasthenia gravis and cervical dystonia

Neurology. 2005 Jun 28;64(12):2155-6. doi: 10.1212/01.WNL.0000165997.77985.32.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Abducens Nerve Diseases / etiology
  • Abducens Nerve Diseases / physiopathology
  • Adult
  • Botulinum Toxins, Type A / administration & dosage*
  • Cholinesterase Inhibitors / adverse effects*
  • Dose-Response Relationship, Drug
  • Esotropia / etiology
  • Esotropia / physiopathology
  • Female
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Injections, Intramuscular
  • Myasthenia Gravis / complications*
  • Myasthenia Gravis / drug therapy
  • Neck Muscles / drug effects*
  • Neck Muscles / physiopathology
  • Oculomotor Muscles / drug effects
  • Oculomotor Muscles / physiopathology
  • Secondary Prevention
  • Torticollis / chemically induced
  • Torticollis / drug therapy*
  • Torticollis / physiopathology
  • Treatment Outcome

Substances

  • Cholinesterase Inhibitors
  • Immunosuppressive Agents
  • Botulinum Toxins, Type A